1980
DOI: 10.1016/0041-008x(80)90069-1
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of ortho-, meta-, and para-toluidine in the adult male rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
1
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(19 citation statements)
references
References 14 publications
1
16
1
1
Order By: Relevance
“…The expected similar range of metabolism and carcinogenic effect is supported by the experimental carcinogenicity. The predicted ring p-hydroxylation is in agreement with the experimental data [56].…”
Section: Docking Resultssupporting
confidence: 82%
See 2 more Smart Citations
“…The expected similar range of metabolism and carcinogenic effect is supported by the experimental carcinogenicity. The predicted ring p-hydroxylation is in agreement with the experimental data [56].…”
Section: Docking Resultssupporting
confidence: 82%
“…As in the case of rat CYP2E1 aniline complex, the LBE values for ortho and para positions were similar, and there was a significant ortho energy contribution. This can explain the experimentally equal range of para and ortho metabolites [56] and the higher carcinogenicity in rat than in mouse. The distance to the Fe atom and LBE values of mouse enzyme were respectively 1.85 Å and À0.97 kcal/mol, which are close to the aniline values for mouse.…”
Section: Docking Resultsmentioning
confidence: 87%
See 1 more Smart Citation
“…The main metabolite is 4-amino-3-methylphenol (synonym 4-amino-m-cresol) and small amounts of the N-hydroxy-derivative are also formed (Son et al, 1980;Kulkarni et al, 1983). Unmetabolized o-toluidine is also excreted in the urine of rats at concentrations that are high (21-36%) in comparison to the noncarcinogenic p-and m-toluidine isomers (2.5% each), and contact of the parent compound with the urinary bladder was proposed as a basis for o-toluidine tumorigenesis in this organ (Cheever et al, 1980). A physiologically based pharmacokinetic model to permit quantitative comparisons between rats and humans, however, is not available.…”
Section: Introductionmentioning
confidence: 96%
“…Radiotracer studies in rats show the oral bioavailability is high, and tissue distribution is widespread. Approximately 92% of the dose was recovered in the urine within 24 h of a 50 mg/kg gavage dose (Cheever et al, 1980;Brock et al, 1990).…”
Section: Introductionmentioning
confidence: 99%